BMC GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2023-03-22 148ac4fbm96(暂无昵称) 来自浙江省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肝病
经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-05-30 ms4000000222994216

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：普外
经验分享：肿瘤，3.15提交，期间修改一次，5.30接收

83 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-12-28 john2525 来自四川省

千万不要投，超级超级慢！3个月了还在initial technical check.

78 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2023-02-22 51780317 来自河北省

各位大咖，这个杂志的个案接受速度快吗

51 0

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-09-01 ms5000000377833445

Editor invited 快一个月了，编辑也要邀请吗

81 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2023-01-09 富国街美食霸来自江苏省

BMC gastroenterology是SCI吗？还是SCIE

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-09-20 小小医者

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌
经验分享：BMC类相对发表容易，不过审稿周期偏长了

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-12-21 Reachu-Chan 来自河北省

接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。

57 0

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-05-13 1202183cm33(暂无昵称)

投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？

90 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2121056, encodeId=6139212105665, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肝病 经验分享：2022.8.8-2023.3.14，非常慢，经历了4次返稿修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ae05321427, createdName=148ac4fbm96(暂无昵称), createdTime=Wed Mar 22 10:12:26 CST 2023, time=2023-03-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115885, encodeId=69d9211588539, content=各位大咖，这个杂志的个案接受速度快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480a2960367, createdName=51780317, createdTime=Wed Feb 22 10:37:12 CST 2023, time=2023-02-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109491, encodeId=d2712109491c9, content=BMC gastroenterology是SCI吗？还是SCIE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd95648602, createdName=富国街美食霸, createdTime=Mon Jan 09 10:19:45 CST 2023, time=2023-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106888, encodeId=8dd9210688814, content=接收后需要什么流程？不太懂后面的流程如何进行？英文也看不懂。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afdc8152364, createdName=Reachu-Chan, createdTime=Wed Dec 21 09:31:47 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103741, encodeId=22a02103e4134, content=投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b235200590, createdName=1473ac61m07暂无昵称, createdTime=Thu Dec 01 17:27:49 CST 2022, time=2022-12-01, status=1, ipAttribution=山西省)]

2022-12-01 1473ac61m07暂无昵称来自山西省

投稿了以后，新系统怎么也打不开了，有人遇到这种情况吗

50 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务